Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pujol

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
British Journal of Cancer|September 1, 1996
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancersJ L Pujol, J Simony, G Jolimoy, et al.
Revue Des Maladies Respiratoires|August 5, 1998
[Biological perspectives]J L Pujol, P Demoly, X Quantin, et al.
The American Review of Respiratory Disease|October 1, 1993
Neural cell adhesion molecule and prognosis of surgically resected lung cancerJ L Pujol, J Simony, P Demoly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)R Gervais, A Ducolone, J-L Breton, et al.
British Journal of Cancer|June 1, 1994
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancerJ L Pujol, A Monnier, J Berille, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancerJ L Pujol, E H Cooper, J Grenier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancerJ L Pujol, J F Rossi, T Le Chevalier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerJ von Pawel, U Gatzemeier, J L Pujol, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
British Journal of Cancer|September 1, 1996
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancersJ L Pujol, J Simony, G Jolimoy, et al.
Revue Des Maladies Respiratoires|August 5, 1998
[Biological perspectives]J L Pujol, P Demoly, X Quantin, et al.
The American Review of Respiratory Disease|October 1, 1993
Neural cell adhesion molecule and prognosis of surgically resected lung cancerJ L Pujol, J Simony, P Demoly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)R Gervais, A Ducolone, J-L Breton, et al.
British Journal of Cancer|June 1, 1994
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancerJ L Pujol, A Monnier, J Berille, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancerJ L Pujol, E H Cooper, J Grenier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancerJ L Pujol, J F Rossi, T Le Chevalier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerJ von Pawel, U Gatzemeier, J L Pujol, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Pageof 16